Loxo Oncology Announces Accepted Abstracts at the IASLC 19th World Conference on Lung Cancer

World News: . []

STAMFORD Conn Aug 10 2018 GLOBE NEWSWIRE -- Loxo Oncology, Inc NasdaqLOXO a biopharmaceutical company developing highly selective medicines for patients with genomically defined cancers today announced that abstracts from its LOXO-292 and la...

More news and information about Loxo Oncology, Inc.

Published By:

Globe Newswire: 21:30 GMT Friday 10th August 2018

Published: .

Search for other references to "loxo" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us